financetom
Business
financetom
/
Business
/
Market Chatter: Starlink, T-Mobile in Talks for EchoStar Spectrum After AT&T Transaction
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Starlink, T-Mobile in Talks for EchoStar Spectrum After AT&T Transaction
Aug 26, 2025 3:06 PM

05:42 PM EDT, 08/26/2025 (MT Newswires) -- Elon Musk's Starlink and T-Mobile (TMUS) have separately expressed interest in acquiring spectrum licenses from EchoStar ( SATS ) , parent of struggling DISH Network, Semafor reported Tuesday, according to people familiar with the matter.

The spectrum represents one of the largest unused blocks of publicly owned airwaves and has attracted regulatory attention urging its sale, said the report.

T-Mobile had earlier considered buying most of EchoStar's ( SATS ) licenses and continues discussions over the portions not acquired by AT&T ( T ) , whereas Musk's Starlink is targeting a segment analysts estimate at roughly $30 billion, it added.

Starlink, EchoStar ( SATS ), and T-Mobile didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources, but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rezolute Gets US FDA Approval for IND Application for RZ358 to Treat Hypoglycemia Caused by Tumor Hyperinsulinism
Rezolute Gets US FDA Approval for IND Application for RZ358 to Treat Hypoglycemia Caused by Tumor Hyperinsulinism
Aug 5, 2024
10:59 AM EDT, 08/05/2024 (MT Newswires) -- Rezolute ( RZLT ) said Monday it has obtained US Food and Drug Administration clearance for an investigational new drug application for a phase 3 trial of RZ358 intended to treat hypoglycemia in people with tumor hyperinsulinism. The company said it is launching start-up activities for the phase 3 trial, which will be...
Fortive Unit Says Sterilization Cycle for Duodenoscopes Gets FDA Clearance
Fortive Unit Says Sterilization Cycle for Duodenoscopes Gets FDA Clearance
Aug 5, 2024
10:57 AM EDT, 08/05/2024 (MT Newswires) -- Fortive's ( FTV ) Advanced Sterilization Products unit said Monday that its new sterilization cycle for duodenoscopes has received clearance from the US Food and Drug Administration. The Ultra GI Cycle, developed in partnership with HOYA's Pentax Medical division, reprocesses duodenoscopes using hydrogen peroxide gas plasma sterilization, the company said. Duodenoscopes have been...
Fox Says Pluto TV to Become Distributor of its Weather Channel
Fox Says Pluto TV to Become Distributor of its Weather Channel
Aug 5, 2024
10:45 AM EDT, 08/05/2024 (MT Newswires) -- Fox (FOX) said Monday that that Pluto TV has become a distributor of its ad-supported streaming weather platform Fox Weather, effective Aug. 1. Terms of the partnership weren't disclosed. Shares of Fox were down more than 2% in recent trading. Price: 34.00, Change: -0.88, Percent Change: -2.52 ...
P10 Extends and Expands Credit Facilities; Shares Fall
P10 Extends and Expands Credit Facilities; Shares Fall
Aug 5, 2024
10:59 AM EDT, 08/05/2024 (MT Newswires) -- P10 (PX) said Monday that it has secured an amended credit agreement, increasing its total credit capacity to $500 million and extending the facilities' maturity to August 2028. The upsized credit capacity comprises $175 million in senior secured revolving credit facility and $325 million in senior secured term loan facility. The amended agreement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved